Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines (vol 126, pg 168, 2000)

被引：0
|
作者：
Yamamoto, K [1 ]
Kikuchi, Y [1 ]
Kudoh, K [1 ]
Nagata, I [1 ]
机构：
[1] Natl Def Med Coll, Dept Obstet & Gynecol, Tokorozawa, Saitama 3598513, Japan
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 2001年 / 127卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：142 / 142
页数：1
相关论文
共 50 条
  • [21] EFFECTS OF A NEW ANTIESTROGEN, IDOXIFENE, ON CISPLATIN-SENSITIVE AND DOXORUBICIN-SENSITIVE AND DOXORUBICIN-RESISTANT HUMAN OVARIAN-CARCINOMA CELL-LINES
    SHARP, SY
    ROWLANDS, MG
    JARMAN, M
    KELLAND, LR
    [J]. BRITISH JOURNAL OF CANCER, 1994, 70 (03) : 409 - 414
  • [22] Difference in expression of Bcl-2 and Bcl-xl genes in cisplatin-sensitive and cisplatin-resistant human in ovarian cancer cell lines
    Yu Lili
    Wang Zehua
    [J]. Current Medical Science, 2004, 24 (2) : 151 - 153
  • [23] Difference in Expression of Bcl-2 and Bcl-xl Genes in Cisplatin-sensitive and Cisplatin-resistant Human in Ovarian Cancer Cell Lines
    于利利
    王泽华
    [J]. Current Medical Science, 2004, (02) : 151 - 153
  • [24] Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cell cycle progression and induction of apoptosis
    Orlandi, L
    Colella, G
    Bearzatto, A
    Abolafio, G
    Manzotti, C
    Daidone, MG
    Zaffaroni, N
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (05) : 649 - 659
  • [25] Spermidine/spermine N1-acetyltranferase modulation by novel folate cycle inhibitors in cisplatin-sensitive and -resistant human ovarian cancer cell lines
    Marverti, Gaetano
    Ligabue, Alessio
    Guerrieri, Davide
    Paglietti, Giuseppe
    Piras, Sandra
    Costi, Maria P.
    Farina, Davide
    Frassineti, Chiara
    Monti, Maria G.
    Moruzzi, Maria S.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 117 (02) : 202 - 210
  • [26] Ovarian cancer cisplatin-resistant cell lines: Multiple changes including collateral sensitivity to Taxol
    Perego, P
    Romanelli, S
    Carenini, N
    Magnani, I
    Leone, R
    Bonetti, A
    Paolicchi, A
    Zunino, F
    [J]. ANNALS OF ONCOLOGY, 1998, 9 (04) : 423 - 430
  • [27] Targeted quantitative analysis of superoxide dismutase 1 in cisplatin-sensitive and cisplatin resistant human ovarian cancer cells
    Kim, Jong Won
    Nie, Bei
    Sahm, Heather
    Brown, Dawn P. G.
    Tegeler, Tony
    You, Jin-Sam
    Wang, Mu
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2010, 878 (7-8): : 700 - 704
  • [28] In vitro combination studies with the sterically hindered platinum drug, ZDO473, in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Rogers, PM
    Boxall, F
    Allott, CP
    Stephens, T
    Kelland, LR
    [J]. CLINICAL CANCER RESEARCH, 2000, 6 : 4537S - 4537S
  • [29] EFFECT OF MODULATION OF PROTEIN-KINASE-C ACTIVITY ON CISPLATIN CYTOTOXICITY IN CISPLATIN-RESISTANT AND CISPLATIN-SENSITIVE HUMAN OSTEOSARCOMA CELLS
    PEREGO, P
    CASATI, G
    GAMBETTA, RA
    SORANZO, C
    ZUNINO, F
    [J]. CANCER LETTERS, 1993, 72 (1-2) : 53 - 58
  • [30] Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and resistant rat lymphoma and human ovarian carcinoma cells
    Parekh, H
    Simpkins, H
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 37 (05) : 457 - 462
12345